ArticleEuropean heart journal open2023

Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathy.

Tatsuya Nishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.